Unraveling Health Mysteries: COVID-19 Origins & DIY Weight-Loss Drugs
The WHO continues to probe COVID-19 origins, yet critical information is lacking. Meanwhile, individuals like Amy Spencer are self-administering unapproved weight-loss drugs amid high prices, highlighting a growing trend beyond FDA regulation.

The World Health Organization (WHO) announced that the investigation into the origins of COVID-19 remains incomplete. Although progress has been made, crucial data necessary to fully evaluate all origin theories is still missing, according to the WHO Scientific Advisory Group.
In a separate development, American consumers, frustrated by the high cost of obesity medications, are turning to self-created weight-loss solutions. Amy Spencer from Missouri, describes the current obesity medicine landscape as a 'wild west' and reportedly administers experimental drugs, including those containing tirzepatide, which are in clinical trials but have not received approval from the U.S. Food and Drug Administration (FDA).
(With inputs from agencies.)
- READ MORE ON:
- WHO
- COVID-19
- virus origin
- weight-loss
- drugs
- obesity
- health
- medication
- trials
- FDA
ALSO READ
Internet scams trigger long-term mental health crisis
Tamil Nadu's Proactive Approach: Mental Health Support for NEET Aspirants
Johns Hopkins, UNDP Launch Global Centre to Tackle Planetary Health Crisis
Sonia Gandhi's Health Update: Stable After Hospitalization
NORCET 2025: Twice-Yearly Nursing Recruitment Boosts India's Healthcare